Jammu and Kashmir has reported a total of 3,468 cervical cancer cases over the past five years, a data presented by the Ministry of Health and Family Welfare in the Parliament reveals.
The year-wise breakdown shows an increase in cases, with 656 in 2019, 676 in 2020, 694 in 2021, 712 in 2022, and 732 in 2023.
The cases increased from 656 in 2019 to 732 in 2023, reflecting a year-on-year rise. Specifically, the number of cases grew by 3.05% from 656 in 2019 to 676 in 2020, 2.66% from 676 to 694 in 2021, 2.59% from 694 to 712 in 2022, and 2.81% from 712 to 732 in 2023.
This rise aligns with a national trend attributed to factors such as an aging population, improved life expectancy, greater awareness, and advances in diagnostic technology. In response, the government has taken measures to make cancer treatment more affordable, including price caps on scheduled cancer drugs, reduced customs duties, and discounts on anticancer medications through the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP).
The government also offers financial assistance through initiatives like the Pradhan Mantri Jan Arogya Yojana (PMJAY), which covers health insurance of Rs 5 lakh per family annually. Additionally, cancer treatment is available at various healthcare facilities, including district hospitals and specialized centers like AIIMS, with AMRIT Pharmacy stores providing cancer drugs at lower prices. Awareness campaigns on prevention and early detection are also being conducted nationwide—(KNO)
